Insider Transactions in Q4 2023 at Biocryst Pharmaceuticals Inc (BCRX)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 19
2023
|
Jon P Stonehouse President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
14,089
-1.25%
|
$84,534
$6.05 P/Share
|
|
Dec 19
2023
|
Helen M. Thackray Chief R&D Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,580
-2.19%
|
$33,480
$6.05 P/Share
|
|
Dec 19
2023
|
Anthony Doyle Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,482
-1.08%
|
$14,892
$6.05 P/Share
|
|
Dec 19
2023
|
Charles K Gayer Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,482
-0.9%
|
$14,892
$6.05 P/Share
|
|
Dec 19
2023
|
Alane P Barnes Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,482
-0.84%
|
$14,892
$6.05 P/Share
|
|
Dec 14
2023
|
Helen M. Thackray Chief R&D Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,031
-1.17%
|
$18,186
$6.43 P/Share
|
|
Dec 14
2023
|
Helen M. Thackray Chief R&D Officer |
BUY
Grant, award, or other acquisition
|
Direct |
51,000
+16.49%
|
-
|
|
Dec 14
2023
|
Charles K Gayer Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,840
-2.06%
|
$35,040
$6.43 P/Share
|
|
Dec 14
2023
|
Charles K Gayer Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
34,000
+10.73%
|
-
|
|
Dec 14
2023
|
Jon P Stonehouse President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
13,592
-1.19%
|
$81,552
$6.43 P/Share
|
|
Dec 14
2023
|
Jon P Stonehouse President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
127,500
+10.04%
|
-
|
|
Dec 14
2023
|
Anthony Doyle Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,475
-2.33%
|
$32,850
$6.43 P/Share
|
|
Dec 14
2023
|
Anthony Doyle Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
34,000
+12.62%
|
-
|
|
Dec 14
2023
|
Alane P Barnes Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,015
-1.34%
|
$24,090
$6.43 P/Share
|
|
Dec 14
2023
|
Alane P Barnes Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
64,000
+17.58%
|
-
|
|
Nov 30
2023
|
Theresa Heggie Director |
BUY
Grant, award, or other acquisition
|
Direct |
956
+1.85%
|
$4,780
$5.88 P/Share
|
|
Nov 30
2023
|
Vincent Milano Director |
BUY
Grant, award, or other acquisition
|
Direct |
956
+1.84%
|
$4,780
$5.88 P/Share
|